prescription drug pricing
Bristol Myers Squibb announces new $2.3bn campus in the US
Texas has been chosen as the site for a new, state-of-the-art multi-modal manufacturing campus
Bristol Myers Squibb’s New Drug Application for mezigdomide accepted by FDA
Mezigdomide improves progression-free survival in patients with relapsed or refractory multiple myeloma
Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate
The drug showed improvements in overall survival and progression-free survival in two cancers
Bristol Myers Squibb evolves and expands multiple myeloma programme
Created in 2016, the Standing in the Gaap programme aims to advance more equitable care
BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma
This type of cancer is the most common one diagnosed in teenagers
Bristol Myers Squibb’s Sotyktu approved by US FDA for psoriatic arthritis
Sotyktu is the first TYK2 inhibitor approved for active psoriatic arthritis
AbbVie reaches agreement for affordable prescription drugs with US government
The pharma company has also pledged a $100bn investment in US infrastructure over the next decade
BMS announces affordable drug price agreement with US government
The company will provide Eliquis, its oral blood thinner, free of charge to Medicaid
Amgen agrees to lower prescription drug costs in deal with US government
The company has invested $40bn in US R&D and manufacturing in the past seven years
Gilead agrees on affordable medicines plan with US government
The company recently announced a $32bn investment in US R&D and manufacturing
Novartis agrees to lower drug prices in deal with US government
In 2025, the pharma company announced a $23bn US investment commitment
Novo Nordisk agrees to lower certain drug prices in the US
The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid